Hui-Li Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hui-Li Cai has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Haidan Chen
Department of Spinal Surgery, The First College of Clinical Medical Science, China Three Gorges University
2 shared publications Han-Sheng Fang
Department of Hematology, The First College of Clinical Medical Science, China Three Gorges University
2 shared publicationsXin-Yue Liu
Department of Hematology, The First College of Clinical Medical Science, China Three Gorges University
2 shared publicationsXu-Yang Zhang
Department of Hematology, The First College of Clinical Medical Science, China Three Gorges University
2 shared publicationsBo Pang
Department of Hematology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China
1 shared publicationHaidan Chen
Department of Spinal Surgery, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1873276
Case Report: Intravascular large B-cell lymphoma presenting with cauda equina syndrome: a rare case and diagnostic dilemma
Objective: To investigate the clinical and diagnostic characteristics of intravascular large B-cell lymphoma (IVLBCL) presenting primarily as cauda equina syndrome (CES), analyze factors contributing to diagnostic delay, and evaluate the diagnostic value of minimally invasive biopsy. Methods: We report a case of IVLBCL that initially presented with CES. The diagnostic process was reviewed by analyzing serum biomarkers and pathology from a random skin biopsy (RSB) that included subcutaneous fat tissue. Additionally, a literature review was conducted via the PubMed database (2005–2025), which identified and analyzed 10 additional cases of IVLBCL with CES as the initial manifestation. Imaging features, clinical symptoms, and time-to-diagnosis were synthesized across these cases. Results: In the present case, the patient presented with progressive lower extremity weakness, saddle anesthesia, and sphincter dysfunction, while early spinal MRI findings were unrevealing. Diagnostically, markedly elevated lactate dehydrogenase (LDH) and interleukin-10 (IL-10) provided key clues, and definitive diagnosis was achieved via a multi-site incisional RSB including subcutaneous fat. In comparison, the 10 literature-retrieved cases ( n = 11 in total) universally demonstrated typical CES but posed significant diagnostic challenges due to the non-specificity of early symptoms and high heterogeneity on initial spinal MRI, which frequently lacked direct space-occupying evidence or appeared entirely normal. Conclusion: Clinicians should maintain a high index of suspicion for IVLBCL in patients presenting with CES when initial imaging findings fail to reflect the clinical severity, particularly when accompanied by systemic laboratory abnormalities such as elevated LDH. While serum IL-10 may serve as a potentially useful adjunctive biomarker to raise diagnostic suspicion, prompt initiation of a RSB enables early detection of this disease and minimizes diagnostic delays.
- 5 August 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1873276
Open AccessCase Report: Intravascular large B-cell lymphoma presenting with cauda equina syndrome: a rare case and diagnostic dilemma
Objective: To investigate the clinical and diagnostic characteristics of intravascular large B-cell lymphoma (IVLBCL) presenting primarily as cauda equina syndrome (CES), analyze factors contributing to diagnostic delay, and evaluate the diagnostic value of minimally invasive biopsy. Methods: We report a case of IVLBCL that initially presented with CES. The diagnostic process was reviewed by analyzing serum biomarkers and pathology from a random skin biopsy (RSB) that included subcutaneous fat tissue. Additionally, a literature review was conducted via the PubMed database (2005–2025), which identified and analyzed 10 additional cases of IVLBCL with CES as the initial manifestation. Imaging features, clinical symptoms, and time-to-diagnosis were synthesized across these cases. Results: In the present case, the patient presented with progressive lower extremity weakness, saddle anesthesia, and sphincter dysfunction, while early spinal MRI findings were unrevealing. Diagnostically, markedly elevated lactate dehydrogenase (LDH) and interleukin-10 (IL-10) provided key clues, and definitive diagnosis was achieved via a multi-site incisional RSB including subcutaneous fat. In comparison, the 10 literature-retrieved cases ( n = 11 in total) universally demonstrated typical CES but posed significant diagnostic challenges due to the non-specificity of early symptoms and high heterogeneity on initial spinal MRI, which frequently lacked direct space-occupying evidence or appeared entirely normal. Conclusion: Clinicians should maintain a high index of suspicion for IVLBCL in patients presenting with CES when initial imaging findings fail to reflect the clinical severity, particularly when accompanied by systemic laboratory abnormalities such as elevated LDH. While serum IL-10 may serve as a potentially useful adjunctive biomarker to raise diagnostic suspicion, prompt initiation of a RSB enables early detection of this disease and minimizes diagnostic delays.
- Open Access
- 12 July 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Chromogenic factor X-guided warfarin monitoring in lupus anticoagulant-positive primary antiphospholipid syndrome with adrenal hemorrhage and progressive deep vein thrombosis: a case report
Antiphospholipid syndrome (APS) is a thrombotic autoimmune disorder; adrenal hemorrhage is uncommon. Treating progressive thrombosis with concurrent major
- 12 July 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Open AccessChromogenic factor X-guided warfarin monitoring in lupus anticoagulant-positive primary antiphospholipid syndrome with adrenal hemorrhage and progressive deep vein thrombosis: a case report
Antiphospholipid syndrome (APS) is a thrombotic autoimmune disorder; adrenal hemorrhage is uncommon. Treating progressive thrombosis with concurrent major
- Open Access
- 29 April 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (5) , 3053-3057
A rare case of type 2A von Willebrand disease with compound heterozygous mutation
Von Willebrand disease (VWD) is defined by a quantitative or qualitative deficiency of von Willebrand factor, which impairs platelet adhesion and aggregation. Here we describe a rare case of type 2A VWD with compound heterozygous mutation. A 27-year-old girl presented with oral bleeding for two days after dental surgery. A systemic physical examination turned up unremarkable. Type 2 von Willebrand disease was confirmed by laboratory tests. Further genetic investigation revealed the existence of compound mutations of VWF (von Willebrand factor) gene, inherited separately from her parents. Interestingly, her mother presented decreased VWF antigen and activity, but that was not found in her father.
- 29 April 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (5) , 3053-3057
Open AccessA rare case of type 2A von Willebrand disease with compound heterozygous mutation
Von Willebrand disease (VWD) is defined by a quantitative or qualitative deficiency of von Willebrand factor, which impairs platelet adhesion and aggregation. Here we describe a rare case of type 2A VWD with compound heterozygous mutation. A 27-year-old girl presented with oral bleeding for two days after dental surgery. A systemic physical examination turned up unremarkable. Type 2 von Willebrand disease was confirmed by laboratory tests. Further genetic investigation revealed the existence of compound mutations of VWF (von Willebrand factor) gene, inherited separately from her parents. Interestingly, her mother presented decreased VWF antigen and activity, but that was not found in her father.